Home/inTRAvent Medical/Sprague W. Hazard III, M.D.

SW

Sprague W. Hazard III, M.D.

Chief Medical Officer & Inventor

inTRAvent Medical

Therapeutic Areas

Neurosurgery Neurocritical Care

inTRAvent Medical Pipeline

Drug	Indication	Phase
SOLOPASS® for EVD Placement	Aiding in frontal placement of intra-ventricular catheters (External Ventricular Drain)	Commercial
SOLOPASS® for Hematoma Evacuation	Hemorrhagic stroke clot aspiration	Pre-clinical

Leadership Team at inTRAvent Medical

Managing Member & CEO

Kevin Foley, M.D., F.A.A.N.S., F.A.C.S.

Chief Innovation Officer

Adam Arthur, MD MPH FAANS FAHA FSNIS

Chief Clinical Strategy Officer

Michael Y. Oh, M.D.

Neurosurgeon & Key Opinion Leader

View full inTRAvent Medical profile